EMA Begins Publishing Names of GMP-Deficient Drugmakers

Drug Industry Daily
A A
In a new enforcement initiative intended to boost drugmaker quality, the European Medicines Agency (EMA) has begun publishing the names of manufacturing facilities that fall out of compliance with good manufacturing practices (GMP).

To View This Article:

Login

Subscribe To Drug Industry Daily